138 related articles for article (PubMed ID: 25223889)
1. TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis.
Paul J; Naskar K; Chowdhury S; Chakraborti T; De T
Biochimie; 2014 Dec; 107 Pt B():235-46. PubMed ID: 25223889
[TBL] [Abstract][Full Text] [Related]
2. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
3. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection.
Paul J; Naskar K; Chowdhury S; Alam MN; Chakraborti T; De T
Indian J Biochem Biophys; 2014 Dec; 51(6):531-41. PubMed ID: 25823227
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase.
Nandan D; Camargo de Oliveira C; Moeenrezakhanlou A; Lopez M; Silverman JM; Subek J; Reiner NE
J Immunol; 2012 Jan; 188(1):367-78. PubMed ID: 22140263
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Zhang P; Katz J; Michalek SM
Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
[TBL] [Abstract][Full Text] [Related]
6. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
[TBL] [Abstract][Full Text] [Related]
10. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events.
Bhattacharyya S; Ghosh S; Jhonson PL; Bhattacharya SK; Majumdar S
Infect Immun; 2001 Mar; 69(3):1499-507. PubMed ID: 11179319
[TBL] [Abstract][Full Text] [Related]
12. Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During
Karmakar J; Mandal C
Front Immunol; 2021; 12():626110. PubMed ID: 33763070
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1.
Gupta P; Srivastav S; Saha S; Das PK; Ukil A
Cell Death Differ; 2016 Nov; 23(11):1815-1826. PubMed ID: 27662364
[TBL] [Abstract][Full Text] [Related]
14. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum.
Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ
Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981
[TBL] [Abstract][Full Text] [Related]
15. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
16. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling.
Adhikari A; Majumder S; Banerjee S; Gupta G; Bhattacharya P; Majumdar SB; Saha B; Majumdar S
J Antimicrob Chemother; 2012 Dec; 67(12):2892-902. PubMed ID: 22879460
[TBL] [Abstract][Full Text] [Related]
19. KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.
Bhaumik S; Basu R; Sen S; Naskar K; Roy S
Vaccine; 2009 Feb; 27(9):1306-16. PubMed ID: 19162111
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 negatively regulates the production of inflammatory cytokines/chemokines and IL-17 in visceral leishmaniasis.
Saha A; Biswas A; Srivastav S; Mukherjee M; Das PK; Ukil A
J Immunol; 2014 Sep; 193(5):2330-9. PubMed ID: 25049356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
